GERRETSON CHARLES E

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$167,262.00
Insider Sells Quantity
2
Insider Sells Sum
$19,760.00

Insider Activity of GERRETSON CHARLES E

The largest purchase of all time was on 2004-07-26 and amounted to 20000 shares of Accelerate Diagnostics, Inc. for $47,000.

The largest sale of all time was on 2009-09-17 and amounted to 4000 shares of Accelerate Diagnostics, Inc. for $13,280.

Biography of GERRETSON CHARLES E

No biography is available at this moment.

2009-09-18SaleAccelerate Diagnostics, Inc.
AXDX
director
2,000
0.0196%
$3.24$6,480-75.08%
2009-09-17SaleAccelerate Diagnostics, Inc.
AXDX
director
4,000
0.0389%
$3.32$13,280-75.75%
2009-02-13PurchaseAccelerate Diagnostics, Inc.
AXDX
director
2,608
0.0228%
$2.10$5,477-26.81%
2009-02-11PurchaseAccelerate Diagnostics, Inc.
AXDX
director
1,792
0.0175%
$2.10$3,763-17.86%
2009-02-09PurchaseAccelerate Diagnostics, Inc.
AXDX
director
1,600
0.0147%
$2.07$3,312-20.68%
2009-02-06PurchaseAccelerate Diagnostics, Inc.
AXDX
director
4,000
0.0391%
$2.02$8,080-11.88%
2005-01-19PurchaseAccelerate Diagnostics, Inc.
AXDX
director
3,000
0.0303%
$2.09$6,280+45.19%
2005-01-18PurchaseAccelerate Diagnostics, Inc.
AXDX
director
20,000
0.2008%
$2.05$41,000+47.32%
2004-12-06PurchaseAccelerate Diagnostics, Inc.
AXDX
director
20,000
0.2008%
$2.15$43,000+39.53%
2004-07-26PurchaseAccelerate Diagnostics, Inc.
AXDX
director
20,000
0.2034%
$2.35$47,000+0.86%
2003-08-06PurchaseAccelerate Diagnostics, Inc.
AXDX
director
1,000
0.0106%
$2.65$2,650+14%
2003-08-05PurchaseAccelerate Diagnostics, Inc.
AXDX
director
2,800
0.0269%
$2.39$6,700+14%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.